NASDAQ
PMD

Psychemedics Corporation

SERVICES-MEDICAL LABORATORIES
LIFE SCIENCES

Prices are adjusted according to historical splits.

Psychemedics Corporation Stock Price

Vitals

Today's Low:
$6.4500
Today's High:
$6.4500
Open Price:
$6.4500
52W Low:
$5.88
52W High:
$8.65
Prev. Close:
$6.5550
Volume:
366

Company Statistics

Market Cap.:
$0.036 billion
Book Value:
2.122
Revenue TTM:
$0.026 billion
Operating Margin TTM:
-1.79%
Gross Profit TTM:
$0.010 billion
Gross Profit TTM:
$0.010 billion
Profit Margin:
-4.52%
Return on Assets TTM:
-1.3%
Return on Equity TTM:
-9.43%

Company Profile

Psychemedics Corporation had its IPO on 1994-02-17 under the ticker symbol PMD.

The company operates in the LIFE SCIENCES sector and SERVICES-MEDICAL LABORATORIES industry. Psychemedics Corporation has a staff strength of 0 employees.

Stock update

Shares of Psychemedics Corporation opened at $6.45 at the start of the last trading session i.e. 2022-11-02.

The stocks traded within a range of $6.45 - $6.45, and closed at $6.45.

This is a -1.6% slip from the previous day's closing price.

A total volume of 366 shares were traded at the close of the day’s session.

In the last one week, shares of Psychemedics Corporation have increased by +7.5%.

Psychemedics Corporation's Key Ratios

Psychemedics Corporation has a market cap of $0.036 billion, indicating a price to book ratio of 3.031 and a price to sales ratio of 1.389.

In the last 12-months Psychemedics Corporation’s revenue was $0.026 billion with a gross profit of $0.010 billion and an EBITDA of $0.002 billion. The EBITDA ratio measures Psychemedics Corporation's overall financial performance and is widely used to measure its profitability.

In the trailing 12-month period, Psychemedics Corporation’s operating margin was -1.79% while its return on assets stood at -1.3% with a return of equity of -9.43%.

In Q2, Psychemedics Corporation’s quarterly earnings growth was a negative -30.2% while revenue growth was a positive 7%.

Psychemedics Corporation’s PE and PEG Ratio

Forward PE
-
Trailing PE
-
PEG
0

Its diluted EPS in the last 12-months stands at $-0.127 per share while it has a forward price to earnings multiple of - and a PEG multiple of 0. A low price to earnings ratio can mean the stock is attractively valued while a high ratio suggests the stock may be overvalued.

The PEG on the other hand provides a broader view compared to the P/E ratio and gives greater insight into Psychemedics Corporation’s profitability.

Psychemedics Corporation stock is trading at a EV to sales ratio of 1.482 and a EV to EBITDA ratio of 12.39. Its price to sales ratio in the trailing 12-months stood at 1.389.

Psychemedics Corporation stock pays annual dividends of $0.19 per share, indicating a yield of 4.33% and a payout ratio of 0%.

Balance sheet and cash flow metrics

Total Assets
$0.000 billion
Total Liabilities
$0.000 billion
Operating Cash Flow
$0.000 billion
Capital Expenditure
$0.000 billion
Dividend Payout Ratio
0%

Psychemedics Corporation ended 1970 with $0.000 billion in total assets and $131.2 billion in total liabilities. Its intangible assets were valued at $0.000 billion while shareholder equity stood at $0.000 billion.

Psychemedics Corporation ended 1970 with $0.000 billion in deferred long-term liabilities, $0.000 billion in other current liabilities, billion in common stock, $0.000 billion in retained earnings and $0.000 billion in goodwill. Its cash balance stood at $0.000 billion and cash and short-term investments were $0.000 billion. The company’s total short-term debt was $0.000 billion while long-term debt stood at $0.000 billion.

Psychemedics Corporation’s total current assets stands at $0.000 billion while long-term investments were $0.000 billion and short-term investments were $0.000 million. Its net receivables were $0.000 billion compared to accounts payable of $0.000 billion and inventory worth $0.000 billion.

In 1970, Psychemedics Corporation's operating cash flow was $0.000 billion while its capital expenditure stood at $0.000 billion.

Comparatively, Psychemedics Corporation paid $0 billion in dividends in 1970.

Other key metrics

Current Trading Price
$6.45
52-Week High
$8.65
52-Week Low
$5.88
Analyst Target Price
$32

Psychemedics Corporation stock is currently trading at $6.45 per share. It touched a 52-week high of $8.65 and a 52-week low of $8.65. Analysts tracking the stock have a 12-month average target price of $32.

Its 50-day moving average was $0 and 200-day moving average was $0 The short ratio stood at indicating a short percent outstanding of 0%.

Around 0% of the company’s stock are held by insiders while 0% are held by institutions.

Frequently Asked Questions About Psychemedics Corporation

The stock symbol (also called stock or share ticker) of Psychemedics Corporation is PMD

The IPO of Psychemedics Corporation took place on 1994-02-17

Similar Industry Stocks (SERVICES-MEDICAL LABORATORIES)

Last Price
Chg
Chg%
$45.78
-3.81
-7.68%
$140.48
-2.3
-1.61%
$0.19
-0
-2.48%
Natera Inc (NTRA)
$45.45
-1.22
-2.61%
$38.48
-1.77
-4.4%

Most Active

Last Price
Chg
Chg%
$58.63
-1.03
-1.73%
$92.12
-4.67
-4.82%
$5.12
-0.61
-10.65%
Apple Inc (AAPL)
$145.03
-5.62
-3.73%
$0.06
0.01
+12.74%

Top Gainers

Last Price
Chg
Chg%
$73
42.7
+140.92%
Oi S.A (OIBR-C)
$0
0
+100%
$0.02
0.01
+100%
$0.25
0.1
+66.44%
$2.85
1.01
+54.86%

Top Losers

Last Price
Chg
Chg%
$5.36
-22.58
-80.82%
$0.02
-0.06
-78.67%
Air T, Inc (AIRTW)
$0.01
-0.03
-75%
$4.51
-5.17
-53.41%
$11.5
-12.2
-51.48%

About

Psychemedics Corporation provides testing services for the detection of drugs of abuse through the analysis of hair samples in the United States, Brazil and internationally. The company is headquartered in Acton, Massachusetts.

Address

125 NAGOG PARK, ACTON, MA, US